Alpha Compute Corp Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-12-09: Form 6-K; Period of report 2016-12-09; Description BIOHAVEN? BHV-0223 IS GRANTED ORPHAN DRUG DESIGNATION IN THE TREATMENT OF AMYOTR; Document pr12916.htm.
- 2016-11-30: Form 6-K; Period of report 2016-11-30; Description PORTAGE ANNOUNCES SPIN-OUT OF EYGEN LIMITED; Document pr113016.htm.
- 2016-11-28: Form 6-K; Period of report 2016-11-27; Description INTERIM FINANCIALS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2016; Document fs93016.htm.
- 2016-11-03: Form 6-K; Period of report 2016-11-03; Description BIOHAVEN RAISES $80 MILLION; Document pr11316.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2016-12-09 | 6-K | 2016-12-09 | BIOHAVEN? BHV-0223 IS GRANTED ORPHAN DRUG DESIGNATION IN THE TREATMENT OF AMYOTR | pr12916.htm |
| 2016-11-30 | 6-K | 2016-11-30 | PORTAGE ANNOUNCES SPIN-OUT OF EYGEN LIMITED | pr113016.htm |
| 2016-11-28 | 6-K | 2016-11-27 | INTERIM FINANCIALS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2016 | fs93016.htm |
| 2016-11-03 | 6-K | 2016-11-03 | BIOHAVEN RAISES $80 MILLION | pr11316.htm |
| 2016-09-21 | 6-K | 2016-09-21 | CHAIRMAN'S LETTER TO SHAREHOLDERS | pr91416.htm |
| 2016-08-30 | 6-K | 2016-08-30 | CONSOLIDATED INTERIM FINANCIALS FOR THE THREE MONTHS ENDED JUNE 30, 2016 AND MAN | 6k83016.htm |
| 2016-08-05 | 6-K | 2016-08-05 | PORTAGE APPOINTS A NEW DIRECTOR | pr8516.htm |
| 2016-07-21 | 6-K | 2016-07-21 | Report of foreign private issuer | pr72016.htm |
| 2016-07-07 | 6-K | 2016-07-05 | FDA CLEARS BIOHAVEN'S IND FOR BHV-4157 ANS PORTAGE TO HOLD INVESTOR CONFERENCE C | pr772016.htm |
| 2016-05-26 | 6-K | 2016-05-26 | PORTAGE ANNOUNCES ORPHAN DRUG DESIGNATION REQUEST GRANTED FTO BIOHAVEN FOR BHV 4 | pr52615.htm |
| 2016-04-27 | 6-K | 2016-04-27 | BIOHAVEN APPOINTS CHIEF COMMERCIAL OFFICER | pr42716.htm |
| 2016-04-07 | 6-K | 2016-04-07 | PORTAGE PROVIDES CORPORATE UPDATES | pr4716.htm |
| 2016-03-23 | 6-K | 2016-03-23 | PORTAGE INVESTS FURTHER IN BIOHAVEN | pr32316.htm |
| 2016-03-21 | 6-K | 2016-03-03 | ORPHAN DRUG DESIGNATION RECEIVED BY BIOHAVEN | pr3316.htm |
| 2016-03-14 | 6-K | 2016-03-14 | ANNOUNCEMENT OF PROPOSED PRIVATE PLACEMENT | pr31416.htm |
| 2016-02-26 | 6-K | 2016-02-26 | THIRD QUARTER 16 FINANCIALS AND MDA | fsmda.htm |
| 2016-02-25 | 6-K | 2016-02-25 | EXPEDITED DEVELOPMENT PATH FOR BHV 0223 FOR BIOHAVEN | pr22516.htm |
| 2016-02-25 | 6-K | 2016-02-25 | POSITIVE RESULTS FROM PHASE 1 STUDY WITH BHV-0223 | pr22416.htm |
| 2016-02-08 | 6-K | 2016-02-08 | NOTICE OF RECORD AND MAILING DATE | nom16.htm |
| 2016-01-25 | 6-K | 2016-01-25 | PORTAGE PROVIDES PPL UPDATES | pr12516.htm |